Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-03

FDA Approved: PROTOPAM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Protopam Chloride (pralidoxime chloride) submitted by Baxter Healthcare Corporation. The action represents appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROTOPAM CHLORIDE (Pralidoxime chloride)

Snippet

SUPPL AP for PROTOPAM CHLORIDE (PRALIDOXIME CHLORIDE)